Brief: Cabaletta Bio Announces Updated Clinical Data With Rese-Cel At February Scientific Meetings
18/02/2025 12:28
Feb 18 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO ANNOUNCES UPDATED CLINICAL DATA
DEMONSTRATING
DEEPENING CLINICAL RESPONSES ACROSS MULTIPLE INDICATIONS WITH
RESE-CEL AT FEBRUARY SCIENTIFIC MEETINGS
Source text: ID:nGNX4rpX96
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview